These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 26062540)

  • 21. Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma.
    Musser ML; Coto GM; Lingnan Y; Mochel JP; Johannes CM
    PLoS One; 2022; 17(12):e0279594. PubMed ID: 36548371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma.
    Sorenmo KU; Baez JL; Clifford CA; Mauldin E; Overley B; Skorupski K; Bachman R; Samluk M; Shofer F
    J Vet Intern Med; 2004; 18(2):209-13. PubMed ID: 15058772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma.
    Finotello R; Stefanello D; Zini E; Marconato L
    Vet Comp Oncol; 2017 Mar; 15(1):25-35. PubMed ID: 25623994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canine hemangiosarcoma treated with standard chemotherapy and minocycline.
    Sorenmo K; Duda L; Barber L; Cronin K; Sammarco C; Usborne A; Goldschmidt M; Shofer F
    J Vet Intern Med; 2000; 14(4):395-8. PubMed ID: 10935889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma.
    Hammer AS; Couto CG; Filppi J; Getzy D; Shank K
    J Vet Intern Med; 1991; 5(3):160-6. PubMed ID: 1920253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
    Bray JP; Orbell G; Cave N; Munday JS
    J Small Anim Pract; 2018 Feb; 59(2):85-91. PubMed ID: 29210452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective evaluation of canine heart base tumours treated with toceranib phosphate (Palladia): 2011-2018.
    Lew FH; McQuown B; Borrego J; Cunningham S; Burgess KE
    Vet Comp Oncol; 2019 Dec; 17(4):465-471. PubMed ID: 31069932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VAC protocol for treatment of dogs with stage III hemangiosarcoma.
    Alvarez FJ; Hosoya K; Lara-Garcia A; Kisseberth W; Couto G
    J Am Anim Hosp Assoc; 2013; 49(6):370-7. PubMed ID: 24051260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective comparison of first-line adjuvant anthracycline vs metronomic-based chemotherapy protocols in the treatment of stage I and II canine splenic haemangiosarcoma.
    Treggiari E; Borrego JF; Gramer I; Valenti P; Harper A; Finotello R; Toni C; Laomedonte P; Romanelli G
    Vet Comp Oncol; 2020 Mar; 18(1):43-51. PubMed ID: 31648405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin chemotherapy for presumptive cardiac hemangiosarcoma in dogs
    Mullin CM; Arkans MA; Sammarco CD; Vail DM; Britton BM; Vickery KR; Risbon RE; Lachowicz J; Burgess KE; Manley CA; Clifford CA
    Vet Comp Oncol; 2016 Dec; 14(4):e171-e183. PubMed ID: 25524594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective evaluation of toceranib (Palladia) treatment for canine metastatic appendicular osteosarcoma.
    Kim C; Matsuyama A; Mutsaers AJ; Woods JP
    Can Vet J; 2017 Oct; 58(10):1059-1064. PubMed ID: 28966355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adjuvant treatment of canine splenic hemangiosarcoma with autologous dendritic cell therapy - a prospective, randomized double-blind study].
    Reck A; Gedon J; Kessler M
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2023 Dec; 51(6):394-402. PubMed ID: 38056478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993).
    Wood CA; Moore AS; Gliatto JM; Ablin LA; Berg RJ; Rand WM
    J Am Anim Hosp Assoc; 1998; 34(5):417-21. PubMed ID: 9728473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with DAV for advanced-stage hemangiosarcoma in dogs.
    Dervisis NG; Dominguez PA; Newman RG; Cadile CD; Kitchell BE
    J Am Anim Hosp Assoc; 2011; 47(3):170-8. PubMed ID: 21498593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017).
    Musser ML; Taikowski KL; Johannes CM; Bergman PJ
    BMC Vet Res; 2018 Sep; 14(1):272. PubMed ID: 30176869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study.
    Lucroy MD; Clauson RM; Suckow MA; El-Tayyeb F; Kalinauskas A
    BMC Vet Res; 2020 Nov; 16(1):447. PubMed ID: 33208160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma.
    Rossi F; Sabattini S; Vascellari M; Marconato L
    Vet Comp Oncol; 2018 Dec; 16(4):497-504. PubMed ID: 29806156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs.
    Berger EP; Johannes CM; Jergens AE; Allenspach K; Powers BE; Du Y; Mochel JP; Fox LE; Musser ML
    J Vet Intern Med; 2018 Nov; 32(6):2045-2053. PubMed ID: 30307656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Survival and Glycemic Control with Toceranib Phosphate and Prednisone for a Metastatic Canine Insulinoma.
    Flesner BK; Fletcher JM; Smithee T; Boudreaux B
    J Am Anim Hosp Assoc; 2019; 55(1):e55105. PubMed ID: 30427714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma.
    Adachi M; Hoshino Y; Izumi Y; Takagi S
    J Vet Med Sci; 2016 May; 78(4):649-56. PubMed ID: 26685984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.